ArticleAIDS care2026
Psychosocial correlates of awareness of HIV pre-exposure prophylaxis (PrEP) among persons who inject drugs in Northeast Georgia.
Article in AIDS care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Despite Georgia having one of the highest rates of new HIV diagnoses in the United States, uptake of HIV pre-exposure prophylaxis (PrEP) remains critically low. We assessed the psychosocial correlates associated with PrEP awareness among persons who inject drugs (PWID) living in Northeast Georgia. Data were collected from 173 adult (≥18 years) HIV-negative PWID. PrEP awareness was elicited by the question, "Have you ever heard of PrEP?" (Yes/No). Covariates include age, gender, sexual orientation, race/ethnicity, education, health insurance, HIV testing, syringe services program (SSP) attendance, psychological stress, resilience, risky sexual and injection behaviors, HIV information seeking, and primary drugs used. Less than half (47.4%) of participants were aware of PrEP. Most participants were interested in asking for PrEP information from providers, obtaining prescriptions, and taking PrEP. In the multivariable analysis, the odds of PrEP awareness were higher among PWID who had higher resilience (adjusted OR: 1.06, 95%CI: 1.02-1.10), ever attended an SSP (adjusted OR: 2.53, 95%CI: 1.21-5.63) and performed sexualized drug use in the last year (adjusted OR: 2.38, 95%CI: 1.01-5.63). PrEP awareness is the first step in the HIV prevention continuum, influencing initiation, use, and persistence. A resilience-based approach in SSP settings may effectively increase PrEP awareness among PWID.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.